Obesity--does it occur in Nigerian children with sickle cell anemia

Samuel Olufemi Akodu1, Ijeoma Nnenna Diaku-Akinwumi, Olisamedua Fidelis Njokanma

  • 1Department of Paediatrics, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria. femiakodu@hotmail.com

Insights

Obesity is present in children with sickle cell anemia in Lagos, Nigeria, affecting 2.5% of those with hemoglobin genotype SS. Public health initiatives should include these vulnerable children in obesity prevention programs.

Area of Science:

  • Pediatrics
  • Public Health
  • Genetics

Background:

  • Children with sickle cell anemia (SCA) often experience growth deficits, making obesity seem unlikely.
  • Understanding the prevalence of obesity in SCA populations is crucial for comprehensive health management.

Purpose of the Study:

  • To determine the prevalence of obesity among children with sickle cell anemia in Lagos, Nigeria.
  • To compare obesity rates between children with SCA and healthy controls.

Main Methods:

  • A random sample of children aged 2-15 years with SCA and healthy controls (hemoglobin genotype AA) were recruited.
  • Anthropometric measurements (weight, height) were taken to calculate Body Mass Index (BMI).
  • Obesity was defined using World Health Organization (WHO) standard criteria for BMI and weight-for-height-for-age.

Main Results:

  • The prevalence of obesity was 2.5% in children with SCA (hemoglobin genotype SS) and 3.8% in controls (hemoglobin genotype AA).
  • Obesity was most prevalent in younger children with SCA and adolescents among controls.
  • All obese children with SCA were from upper socioeconomic strata.

Conclusions:

  • Obesity is a reality among children with sickle cell anemia in Lagos.
  • Public health strategies for obesity prevention and control must actively include children with SCA.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...